The DOI matches its Crossref record.
COURSE AND PROGNOSIS OF MULTIPLE SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA PROCESSING OF 349 PATIENTS
Abstract
The information of 349 cases of multiple sclerosis, seen in a neurological department over a twenty-year period and followed up for a mean of nine years, was analysed by computerized data processing. The mean age at onset was 30.0 years for the remittent onset types (82 per cent cases) and 37.3 years for the progressive onset types (18 per cent cases). During the course of the disease the age of the 'pure relapse' stage was 29.2 years, of the relapse with sequelae stage 33.9 years and of the progressive phase 38.0 years. The interval between the first two relapses in the remittent-progressive type was important, the shorter the interval the sooner the progressive phase occurred. The relapses tended to increase in frequency before the progressive phase started. Using an actuarial graph, 50 per cent of cases could be expected to be moderately disabled (still ambulatory) in six years, and severely disabled (not ambulatory) in eighteen years and dead in thirty years. Combining a disability score and the duration of the disease prognostic factors could be studied. A late onset of the disease, a short interval between the first two relapses and the occurrence of the progressive phase were associated with a poor outcome. Sex of patient, the symptomatology of the initial relapses, and the constituents of the CSF had no prognostic value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390501 · Cited by 1,559
Self-citationRelapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Self-citationDevelopment of a multiple sclerosis functional composite as a clinical trial outcome measure
Cutter, G. R. (1999) · Brain · doi:10.1093/brain/122.5.871 · Cited by 1,190
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Comi, G., Filippi, M., Barkhof, F., Durelli, L., Edan, G., Fernández, O., Hartung, H.-P., Seeldrayers, P., Sørensen, P. S., Rovaris, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04725-5 · Cited by 1,053
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Self-citationSex ratio of multiple sclerosis in Canada: a longitudinal study
Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 921
Natural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 905
Self-citationA longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861
Scalfari, A., Neuhaus, A., Degenhardt, A., Rice, G. P., Muraro, P. A., Daumer, M., & Ebers, G. C. (2010) · Brain · doi:10.1093/brain/awq118 · Cited by 711
Multiple sclerosis: clinical aspects
Oh, J., Vidal-Jordana, A., & Montalban, X. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000622 · Cited by 620
Natural History of Multiple Sclerosis with Childhood Onset
Renoux, C., Vukusic, S., Mikaeloff, Y., Edan, G., Clanet, M., Dubois, B., Debouverie, M., Brochet, B., Lebrun-Frenay, C., Pelletier, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067597 · Cited by 598
Self-citationMajor depression in multiple sclerosis: A population-based perspective
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095964.34294.b4 · Cited by 529
Age at disability milestones in multiple sclerosis
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awh714 · Cited by 525
Self-citationHLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
Olerup, O., & Hillert, J. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb02029.x · Cited by 490
Vaccinations and the Risk of Relapse in Multiple Sclerosis
Confavreux, C., Suissa, S., Saddier, P., Bourdès, V., & Vukusic, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440501 · Cited by 490
Self-citationMajor differences in the dynamics of primary and secondary progressive multiple sclerosis
Thompson, A. J., Kermode, A. G., Wicks, D., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E., & McDonald, W. I. (1991) · Annals of Neurology · doi:10.1002/ana.410290111 · Cited by 486
MCOMBE, P. A., POLLARD, J. D., & MCLEOD, J. G. (1987) · Brain · doi:10.1093/brain/110.6.1617 · Cited by 458
Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Gorman, M. P., Healy, B. C., Polgar-Turcsanyi, M., & Chitnis, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.505 · Cited by 454
The natural history of multiple sclerosis with childhood onset
Renoux, C., Vukusic, S., & Confavreux, C. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.04.009 · Cited by 450
Self-citationKremenchutzky, M., Rice, G. P. A., Baskerville, J., Wingerchuk, D. M., & Ebers, G. C. (2006) · Brain · doi:10.1093/brain/awh721 · Cited by 447
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain · doi:10.1093/brain/aws189 · Cited by 386
Helping others helps oneself: response shift effects in peer support
Schwartz, C. E., & Sendor, R. M. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00049-0 · Cited by 389
Neuropsychology of multiple sclerosis: A critical review
Rao, S. M. (1986) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638608405173 · Cited by 387
Milligan, N. M., Newcombe, R., & Compston, D. A. (1987) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.5.511 · Cited by 364
Course and prognosis in early-onset MS: Comparison with adult-onset forms
Simone, I. L., Carrara, D., Tortorella, C., Liguori, M., Lepore, V., Pellegrini, F., Bellacosa, A., Ceccarelli, A., Pavone, I., & Livrea, P. (2002) · Neurology · doi:10.1212/01.wnl.0000036907.37650.8e · Cited by 343
Mikaeloff, Y., Suissa, S., Vallée, L., Lubetzki, C., Ponsot, G., Confavreux, C., Tardieu, M., & KIDMUS Study Group (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.10.056 · Cited by 321
Self-citationEDMUS, a European database for multiple sclerosis.
Confavreux, C., Compston, D. A., Hommes, O. R., McDonald, W. I., & Thompson, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.671 · Cited by 313
Self-citationThe Natural History of Multiple Sclerosis
Weinshenker, B. G. (1995) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30064-1 · Cited by 313
Multiple sclerosis in childhood: clinical features of 149 cases
Ghezzi, A., Deplano, V., Faroni, J., Grasso, M., Liguori, M., Marrosu, G., Pozzilli, C., Simone, I., & Zaffaroni, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300105 · Cited by 309
Quality of life in multiple sclerosis: Measuring the disease effects more broadly
Nortvedt, M. W., Riise, T., Myhr, K., & Nyland, H. I. (1999) · Neurology · doi:10.1212/wnl.53.5.1098 · Cited by 307
Secondary progressive multiple sclerosis: current knowledge and future challenges
Rovaris, M., Confavreux, C., Furlan, R., Kappos, L., Comi, G., & Filippi, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70410-0 · Cited by 303
Self-citationClinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
Cree, B. A. C., Khan, O., Bourdette, D., Goodin, D. S., Cohen, J. A., Marrie, R. A., Glidden, D., Weinstock-Guttman, B., Reich, D., Patterson, N., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145762.60562.5d · Cited by 301
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
Thompson, A. J., Kermode, A. G., MacManus, D. G., Kendall, B. E., Kingsley, D. P., Moseley, I. F., & McDonald, W. I. (1990) · BMJ · doi:10.1136/bmj.300.6725.631 · Cited by 288
Age and disability accumulation in multiple sclerosis
Scalfari, A., Neuhaus, A., Daumer, M., Ebers, G. C., & Muraro, P. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318230a17d · Cited by 279
Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan
Desai, M. K., & Brinton, R. D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00265 · Cited by 273
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics
Minden, S. L., Frankel, D., Hadden, L., Perloff, J., Srinath, K. P., & Hoaglin, D. C. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1262oa · Cited by 272
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
Tutuncu, M., Tang, J., Zeid, N. A., Kale, N., Crusan, D. J., Atkinson, E. J., Siva, A., Pittock, S. J., Pirko, I., Keegan, B. M., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512451510 · Cited by 267
Depression and anxiety amongst multiple sclerosis patients
Beiske, A. G., Svensson, E., Sandanger, I., Czujko, B., Pedersen, E. D., Aarseth, J. H., & Myhr, K. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02041.x · Cited by 257
Hawkins, S. A., & McDonnell, G. V. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.2.148 · Cited by 260
Chitnis, T., Glanz, B., Jaffin, S., & Healy, B. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508101933 · Cited by 260
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
Sucksdorff, M., Matilainen, M., Tuisku, J., Polvinen, E., Vuorimaa, A., Rokka, J., Nylund, M., Rissanen, E., & Airas, L. (2020) · Brain · doi:10.1093/brain/awaa275 · Cited by 142
Clinical characteristics of patients with late-onset multiple sclerosis
Kis, B., Rumberg, B., & Berlit, P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0778-x · Cited by 137
Early MRI in optic neuritis: The risk for disability
Swanton, J. K., Fernando, K. T., Dalton, C. M., Miszkiel, K. A., Altmann, D. R., Plant, G. T., Thompson, A. J., & Miller, D. H. (2009) · Neurology · doi:10.1212/01.wnl.0000341935.41852.82 · Cited by 94
Ismail, A., Cooper-Knock, J., Highley, J. R., Milano, A., Kirby, J., Goodall, E., Lowe, J., Scott, I., Constantinescu, C. S., Walters, S. J., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303326 · Cited by 65
Early predictors of conversion to secondary progressive multiple sclerosis
Barzegar, M., Najdaghi, S., Afshari-Safavi, A., Nehzat, N., Mirmosayyeb, O., & Shaygannejad, V. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103115 · Cited by 52
Link of the mechanisms of action of glatiramer acetate to its long-term clinical data.
Moreau, T. (2009) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(09)70005-x · Cited by 2
Metadata
- Authors
- CONFAVREUX, C., AIMARD, G., & DEVIC, M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1980
- Volume
- 103
- Issue
- 2
- Pages
- 281-300
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2128514970
- Cited by
- 494
- References
- 0
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.